patent/IN-2015DN00837-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2015DN00837-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4af806150bcef5212e861266011b7309
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0061
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-24
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-22
filingDate	2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bffbd93cbe20ab58a4ce3534aa40e650 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6500766de7782d88befed87bfe45d807 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86348b95cd612184842363f83983e649 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff83317002ffa012c8c4946040ebffac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a34bc2ac3190f466d5c692c1146b2fb
publicationDate	2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	IN-2015DN00837-A
abstract	The invention relates to new derivatives of 5-aminolevulinic acid (5-ALA) and their use as photosensitizing agents. In particular, it relates to compounds of general formula I and their pharmaceutically acceptable salts, to methods for preparing such compounds and their medical and cosmetic use, for example in methods of photodynamic therapy and diagnosis: wherein R 1 represents a hydrogen atom or an optionally substituted alkyl or cycloalkyl group; R2, each of which may be the same or different, represents a hydrogen atom or an optionally substituted alkyl group; and X is a linking group.
priorityDate	2012-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558200

Total number of triples: 31.